🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Physiology to Evaluate Procedural Result After PCI CTO

RecruitingNAAges 18 Years - anyAllIsala
NCT04780971 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

ULTRA-CTO is a prospective multicentre non-randomised investigator-initiated trial designed to enrol 200 subjects with an indication for percutaneous coronary intervention (PCI) of chronic total occluded (CTO) coronary artery. The main objective of the study is to assess the predictive value of post-PCI resting full-cycle ratio (RFR) and fractional flow reserve (FFR) with regard to Fractional flow reserve (SSR) in CTO patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 18 years and older. 2. Angiographically successful PCI CTO without any remaining lesion at least 30% proximal to the stented segment. 3. Possibility to perform physiologic measurements and OCT of sufficient quality. 4. Patients willing and capable to provide written informed consent. Exclusion Criteria: 1\) Contra-indication for adenosine.
💊

What it tests

  • post-PCI Pd/Pa
📍

Where

2 sites
Radboud UMC
Nijmegen, Netherlands
Isala
Zwolle, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy